# An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

> **NCT00297323** · — · COMPLETED · sponsor: **Janssen Cilag Pharmaceutica S.A.C.I., Greece** · enrollment: 80 (actual)

## Conditions studied

- Seizures, Epileptic

## Interventions

- **DRUG:** Topiramate

## Key facts

- **NCT ID:** NCT00297323
- **Lead sponsor:** Janssen Cilag Pharmaceutica S.A.C.I., Greece
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2010-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297323, "An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00297323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*